WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008093825) CAFFEINE ANALOG
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/093825    International Application No.:    PCT/JP2008/051627
Publication Date: 07.08.2008 International Filing Date: 01.02.2008
IPC:
C07D 471/14 (2006.01), A61K 31/519 (2006.01), A61P 9/10 (2006.01), A61P 25/20 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01), C07B 61/00 (2006.01)
Applicants: National University Corporation Hokkaido University [JP/JP]; 8, Kita 8-jyo Nishi 5-chome, Kita-ku, Sapporo-shi Hokkaido 0600808 (JP) (For All Designated States Except US).
Tokyo Metropolitan Organization for Medical Research [JP/JP]; 8-1, Nishi-Shinjuku 2-chome, Shinjuku-ku, Tokyo 1638001 (JP) (For All Designated States Except US).
KOBAYASHI, Jun'ichi [JP/--]; (For US Only).
ISHIYAMA, Haruaki [JP/--]; (For US Only).
OHSHITA, Kengo [JP/--]; (For US Only).
NAKATA, Hiroyasu [JP/--]; (For US Only)
Inventors: KOBAYASHI, Jun'ichi; .
ISHIYAMA, Haruaki; .
OHSHITA, Kengo; .
NAKATA, Hiroyasu;
Agent: HOSHINO, Tetsuro; c/o TOKYO CENTRAL PATENT FIRM 3rd Floor, Oak Building Kyobashi 16-10, Kyobashi 1-chome Chuou-ku, Tokyo 1040031 (JP)
Priority Data:
2007-024575 02.02.2007 JP
Title (EN) CAFFEINE ANALOG
(FR) ANALOGUE DE LA CAFÉINE
(JA) カフェイン類縁体
Abstract: front page image
(EN)Disclosed is a caffeine analog represented by the general formula (1) below or the general formula (2) below, or a pharmacologically acceptable salt thereof as a novel compound acting on an adenosine receptor. (1) (2) (In the formulae (1) and (2), R1, R2 and R3 independently represent a hydrogen atom or an alkyl group having 1-3 carbon atoms.)
(FR)L'invention porte sur un analogue de la caféine représenté par la formule générale (1) ci-après ou par la formule générale (2) ci-après, ou sur un sel pharmacologiquement acceptable de ceux-ci, comme nouveau composé agissant sur un récepteur de l'adénosine. (1) (2) (Dans les formules (1) et (2), R1, R2 et R3 représentent indépendamment un atome d'hydrogène ou un groupe alkyle ayant 1-3 atomes de carbone).
(JA)アデノシンレセプターに作用する新規な化合物として、一般式(1)あるいは一般式(2)で示されるカフェイン類縁体、および薬理学的に許容される塩を提供する。 (式(1)および式(2)中、R、RおよびRは、それぞれ水素原子あるいは炭素数1から3のアルキル基である。)
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)